The OVA Resources

Resources

Here you will find a variety of practical resources with collaborating partners of The OVA.
Additional training videos may be found in the "Trainings" Tab. All Links are interactive.
‍

Severe Maternal Morbidity Calculations Report
View Document
Preconception Care and Severe Maternal Morbidity
in the United States
View Document
MMRC Report 2010-2012
View Document
MMRC Report 2020
View Document

Reports from the Pennsylvania Department of Health on Maternal Morbidity

2021 Report: Pennsylvania Maternal Mortality Review
Access Report December 2020: Pregnancy Associated Deaths
in Pennsylvania, 2013 – 2018
Access Report
May 2015: Maternal Mortality in Philadelphia, 2010-2012
Access Report
2020: Maternal Mortality in Philadelphia
Access Report
City of Philadelphia: Health of the City Reports
Access Report

Other Helpful Materials & Reports

March of Dimes
Nowhere to Go: Maternity Care Deserts Across the US (2022 Report)
View Website
The Uneven Burden of Maternal Mortality in the U.S.
View Website Pregnancy-Related Deaths Among American Indian or Alaska Native Persons: Data from MMRCs in 36 US States, 2017–2019
View Website Pregnancy-Related Deaths: Data from Maternal Mortality Review Committees in 36 US States, 2017–2019
View Website The Commonwealth Fund 2021 - Severe Maternal Morbidity
in the United States: A Primer
View Website CDC - Vital Signs: Pregnancy-Related Deaths, United States
2011-2015, and Strategies for Prevention, 13 states, 2013-2017
View Website
Pennsylvania Perinatal Quality Collaborative
View Website
Review to Action
View Website

Resources from the Philadelphia Department of Public Health and the OVA

If you are interested in having your website presented as a resource please contact ova@phila.gov

Treatment in Pregnancy for Hepatitis C (TiP-HepC) Clinical Case Registry

Created by the Coalition for Global Hepatitis Elimination a program of The Taskforce for Global Health

Direct-acting antiviral (DAA) medications have demonstrated excellent safety and efficacy in the treatment of hepatitis C virus (HCV) non-pregnant individuals, but there is a lack of data regarding the safety of these medications in pregnant women and the effectiveness of these medications in reducing mother-to-child transmission. This registry was created to record outcomes of mother-infant pairs exposed to DAAs during pregnancy. Findings from the registry will be critical to advancing HCV treatment decision-making by clinical providers and programs worldwide.